Damien Alan Perriman - 01 Apr 2026 Form 4 Insider Report for EXOZYMES INC. (EXOZ)

Reporting relationship: Chief Commercial Officer
Issuer ticker: EXOZ
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Apr 2026, 19:22:21 UTC
Source filing: View source filing
Reporting owner signature: /s/ Damien Perriman

Key filing fact

Damien Alan Perriman filed Form 4 for EXOZYMES INC. (EXOZ) on 08 Apr 2026.

Key facts

This page summarizes Damien Alan Perriman's Form 4 filing for EXOZYMES INC. (EXOZ).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Apr 2026, 19:22.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002096714 Primary reporting owner

Perriman Damien Alan

Relationship: Chief Commercial Officer
Address: C/O 750 ROYAL OAKS DRIVE,, SUITE 106, SAN DIEGO
Signature: /s/ Damien Perriman
Signature date: 08 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXOZ transaction

Restricted Stock Grant for Common Stock

Award

Transaction value
Shares: +62,759
Change %
Price: $0.000000^*
Shares after: 62,759
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXOZ transaction Derivative

Stock Option for Common Stock

Award

Transaction value
Shares: +146,437
Change %
Price: $0.000000^*
Shares after: 146,437
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 146,437
Exercise price: $9.49
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares underlying the grant of the restricted stock vest at a rate of 3,923 shares per quarter, with 15,689 shares vesting immediately. The final vesting installment consists of 3,917 shares on April 1, 2029. The grant and each vesting is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended.

Footnote F2

The shares underlying the stock option grant vest at a rate of 3,050 shares per month, with 36,609 shares vesting immediately. The final vesting installment consists of 3,078 shares on April 1, 2029. The grant and each exercise of the option is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended.